<b>CD44 variant 9 expression as a predictor for gastric cancer recurrence: immunohistochemical and metabolomic analysis of surgically resected </b><b>tissues </b>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD44 variant 9 expression as a predictor for gastric cancer recurrence: immunohistochemical and metabolomic analysis of surgically resected tissues

Published:2017 Issue:1 Volume:38 Page:41-52
ISSN:0388-6107
Container-title:Biomedical Research
language:en
Short-container-title:Biomed. Res.

Author:

YAMAKAWA Yushi¹²,KUSUHARA Masatoshi³,TERASHIMA Masanori⁴,KINUGASA Yusuke¹,SUGINO Takashi⁵,ABE Masato⁵,MOCHIZUKI Toru⁶,HATAKEYAMA Keiichi⁶,KAMI Kenjiro⁷,YAMAGUCHI Ken⁸

Affiliation:

1. Division of Colon and Rectal Surgery, Shizuoka Cancer Center

2. Department of Surgery, School of Medicine, Keio University

3. Regional Resources Division, Shizuoka Cancer Center Research Institute

4. Division of Gastric Surgery, Shizuoka Cancer Center

5. Division of Pathology, Shizuoka Cancer Center

6. Medical Genetics Division, Shizuoka Cancer Center Research Institute

7. Human Metabolome Technologies, Inc., Tsuruoka

8. Shizuoka Cancer Center

Publisher

Biomedical Research Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/biomedres/38/1/38_41/_pdf

Reference52 articles.

1. 1 International Agency for Research on Cancer WHO (2012) GLOBOCAN 2012. Estimated cancer incidence, mortality and prevalence.

2. 2 Al Hajj M, Wicha M, Benito Hernandez A, Morrison S and Clarke M (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100, 3983–3988.

3. 3 Aruffo A, Stamenkovic I, Melnick M, Underhill CB and Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61, 1303–1313.

4. 4 Aso T, Matsuo M, Kiyohara H, Taguchi K, Rikimaru F, et al. (2015) Induction of CD44 variant 9-expressing cancer stem cells might attenuate the efficacy of chemoradioselection and Worsens the prognosis of patients with advanced head and neck cancer. PloS One 10, e0116596–e0116596.

5. 5 Betsunoh H, Fukuda T, Anzai N, Nishihara D, Mizuno T, et al. (2013) Increased expression of system large amino acidtransporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma. BMC Cancer 13, 509–509.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and prognostic value of CD44v9 and TIM3 expression in CK^‑ and CK⁺ regions in gastric cancer tissues;Oncology Letters;2024-08-06

2. A Narrative Review on CD44’s Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence;Cancers;2023-10-09

3. Characteristics of Cancer Epidemiology Studies That Employ Metabolomics: A Scoping Review;Cancer Epidemiology, Biomarkers & Prevention;2023-07-06

4. Late recurrent gastric carcinoma 12 years after surgery with attenuation of CD44 variant 9 expression;Surgical Case Reports;2023-05-22

5. Late recurrence of CD44 variant 9-positive gastric carcinoma 12 years after surgery: A case report;2023-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3